1. Do sleep changes mediate the anti‐depressive and anti‐suicidal response of intravenous ketamine in treatment‐resistant depression?. (16th June 2021) Authors: Rodrigues, Nelson B.; McIntyre, Roger S.; Lipsitz, Orly; Cha, Danielle S.; Cao, Bing; Lee, Yena; Gill, Hartej; Lui, Leanna M. W.; Cubała, Wiesław J.; Ho, Roger; Shekotikhina, Margarita; Teopiz, Kayla M.; Subramaniapillai, Mehala; Kratiuk, Kevin; Mansur, Rodrigo B.; Rosenblat, Joshua D. Journal: Journal of sleep research Issue: Volume 31:Number 1(2022) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Intravenous ketamine for postmenopausal women with treatment-resistant depression: Results from the Canadian Rapid Treatment Center of Excellence. (April 2021) Authors: Lipsitz, Orly; McIntyre, Roger S.; Rodrigues, Nelson B.; Lee, Yena; Cha, Danielle S.; Gill, Hartej; Subramaniapillai, Mehala; Kratiuk, Kevin; Lin, Kangguang; Ho, Roger; Mansur, Rodrigo B.; Rosenblat, Joshua D. Journal: Journal of psychiatric research Issue: Volume 136(2021) Page Start: 444 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Ketamine monotherapy versus adjunctive ketamine in adults with treatment-resistant depression: Results from the Canadian Rapid Treatment Centre of Excellence. (November 2021) Authors: Di Vincenzo, Joshua D.; Lipsitz, Orly; Rodrigues, Nelson B.; Lee, Yena; Gill, Hartej; Kratiuk, Kevin; Subramaniapillai, Mehala; Mansur, Rodrigo; McIntyre, Roger S.; Rosenblat, Joshua D. Journal: Journal of psychiatric research Issue: Volume 143(2021) Page Start: 209 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Rapastinel - an investigational NMDA-R modulator for major depressive disorder: evidence to date. (1st February 2019) Authors: Ragguett, Renee-Marie; Rong, Carola; Kratiuk, Kevin; McIntyre, Roger S. Journal: Expert opinion on investigational drugs Issue: Volume 28:Number 2(2019) Page Start: 113 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Real world effectiveness of repeated ketamine infusions for treatment-resistant depression with comorbid borderline personality disorder. (May 2023) Authors: Danayan, Kevork; Chisamore, Noah; Rodrigues, Nelson B.; Vincenzo, Joshua D. Di; Meshkat, Shakila; Doyle, Zoe; Mansur, Rodrigo; Phan, Lee; Fancy, Farhan; Chau, Edmond; Tabassum, Aniqa; Kratiuk, Kevin; Arekapudi, Anil; Teopiz, Kayla M.; McIntyre, Roger S.; Rosenblat, Joshua D. Journal: Psychiatry research Issue: Volume 323(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Real-world effectiveness of repeated ketamine infusions for treatment resistant depression during the COVID-19 pandemic. (September 2021) Authors: Rosenblat, Joshua D.; Lipsitz, Orly; Di Vincenzo, Joshua D.; Rodrigues, Nelson B.; Kratiuk, Kevin; Subramaniapillai, Mehala; Lee, Yena; Arekapudi, Anil K.; Abrishami, Amir; Chau, Edmond H.; Szpejda, Witold; Wong, Leslie; Mansur, Rodrigo B.; McIntyre, Roger S. Journal: Psychiatry research Issue: Volume 303(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Safety and tolerability of IV ketamine in adults with major depressive or bipolar disorder: results from the Canadian rapid treatment center of excellence. Issue 8 (2nd August 2020) Authors: Rodrigues, Nelson B.; McIntyre, Roger S.; Lipsitz, Orly; Lee, Yena; Cha, Danielle S.; Nasri, Flora; Gill, Hartej; Lui, Leanna M.W.; Subramaniapillai, Mehala; Kratiuk, Kevin; Lin, Kangguang; Ho, Roger; Mansur, Rodrigo B.; Rosenblat, Joshua D. Journal: Expert opinion on drug safety Issue: Volume 19:Issue 8(2020) Page Start: 1031 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. The effect of intravenous ketamine on cognitive functions in adults with treatment-resistant major depressive or bipolar disorders: Results from the Canadian rapid treatment center of excellence (CRTCE). (August 2021) Authors: McIntyre, Roger S.; Rosenblat, Joshua D.; Rodrigues, Nelson B.; Lipsitz, Orly; Chen-Li, David; Lee, Jung Goo; Nasri, Flora; Subramaniapillai, Mehala; Kratiuk, Kevin; Wang, Andrew; Gill, Hartej; Mansur, Rodrigo B.; Ho, Roger; Lin, Kangguang; Lee, Yena Journal: Psychiatry research Issue: Volume 302(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. The effect of repeated doses of intravenous ketamine on measures of workplace attendance and productivity in adults with major depressive and bipolar disorder: Results from the canadian rapid treatment center of excellence. (June 2021) Authors: Rodrigues, Nelson B.; McIntyre, Roger S.; Lipsitz, Orly; Lee, Yena; Subramaniapillai, Mehala; Kratiuk, Kevin; Majeed, Amna; Nasri, Flora; Gill, Hartej; Mansur, Rodrigo B.; Rosenblat, Joshua D. Journal: Psychiatry research Issue: Volume 300(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. The effectiveness of intravenous ketamine in adults with treatment-resistant major depressive disorder and bipolar disorder presenting with prominent anxiety: Results from the Canadian Rapid Treatment Center of Excellence. (February 2021) Authors: McIntyre, Roger S; Rodrigues, Nelson B; Lipsitz, Orly; Nasri, Flora; Gill, Hartej; Lui, Leanna MW; Subramaniapillai, Mehala; Kratiuk, Kevin; Teopiz, Kayla; Ho, Roger; Lee, Yena; Mansur, Rodrigo B; Rosenblat, Joshua D Journal: Journal of psychopharmacology Issue: Volume 35:Number 2(2021) Page Start: 128 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗